Detalhe da pesquisa
1.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Lancet
; 399(10321): 237-248, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953526
2.
Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada1.
Emerg Infect Dis
; 26(3): 454-462, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32091358
3.
Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
J Clin Microbiol
; 58(7)2020 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321781
4.
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
J Infect Dis
; 218(3): 378-387, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617814
5.
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
Clin Infect Dis
; 67(7): 1063-1071, 2018 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010773
6.
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People.
J Infect Dis
; 216(4): 405-414, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931244
7.
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.
CMAJ
; 189(24): E819-E827, 2017 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28630358
8.
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
BMC Infect Dis
; 17(1): 805, 2017 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284435
9.
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.
Open Forum Infect Dis
; 10(7): ofad315, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441353
10.
High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults.
HIV Clin Trials
; 13(1): 23-32, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22306585
11.
Healthcare provider awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers.
Hum Vaccin Immunother
; 18(7): 2147356, 2022 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472081
12.
Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary disease.
Influenza Other Respir Viruses
; 16(6): 1172-1182, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36069141
13.
Older Age and Frailty are Associated with Higher Mortality but Lower ICU Admission with COVID-19.
Can Geriatr J
; 25(2): 183-196, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747412
14.
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay.
Vaccine
; 40(18): 2635-2646, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35315326
15.
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.
Vaccine
; 38(6): 1384-1392, 2020 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843270
16.
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.
Vaccines (Basel)
; 8(3)2020 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698532
17.
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015.
BMJ Open Respir Res
; 7(1)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188585
18.
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
Vaccine
; 37(36): 5466-5473, 2019 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345638
19.
Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.
Chest
; 155(1): 69-78, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30616737
20.
Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.
Influenza Other Respir Viruses
; 12(2): 232-240, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29125689